鲁抗医药：注射用头孢唑肟钠获药品注册证书

Group 1 - The company received a drug registration certificate from the National Medical Products Administration for injectable Cefoperazone Sodium [1] - Cefoperazone Sodium is a third-generation cephalosporin with broad-spectrum antibacterial properties [1] - The approved registration numbers are National Drug Approval Code H20254488 and H20254489 [1] Group 2 - The company has invested approximately 2.9455 million yuan in research and development as of the announcement date [1] - The projected sales revenue for injectable Cefoperazone Sodium in Chinese urban public hospitals is expected to reach 3.078 billion yuan in 2024 [1]